Sam Mallard - The Case of The Missing Swan

What I liked is that it doesn’t frame enclomiphene as either a breakthrough or a failure. It sits in that middle zone where evidence is promising but still incomplete. That’s probably the most honest way to describe it right now. I also found the discussion around patient demand and clinical interest quite relevant. It explains why the topic is still active even without major new approvals. https://valhallavitality.com/blog/enclomiphene-is-a-natural-way-to-boost-testosterone

What stood out to me in the 2026 updates is that there still isn’t a single breakthrough moment, but rather a slow accumulation of interpretation and clinical discussion. It feels more like the field is refining how enclomiphene fits into practice rather than discovering something completely new. I also like that the article separates actual evidence from hype, which is rare in this space. The focus on context makes it easier to understand where things realistically stand. Overall, it reads more like a status update than a headline piece. https://valhallavitality.com/blog/enclomiphene-is-a-natural-way-to-boost-testosterone